Loading...
XSHE
300760
Market cap37bUSD
Apr 03, Last price  
225.27CNY
1D
-2.00%
1Q
-7.55%
IPO
191.42%
Name

Shenzhen Mindray Bio-Medical Electronics Co Ltd

Chart & Performance

D1W1MN
No data to show
P/E
23.54
P/S
7.81
EPS
9.57
Div Yield, %
2.47%
Shrs. gr., 5y
1.71%
Rev. gr., 5y
20.49%
Revenues
34.93b
+15.04%
7,835,717,6008,013,109,7269,031,723,19411,173,795,36413,753,357,46916,555,991,31421,025,846,38925,269,580,81830,365,643,81134,931,900,884
Net income
11.58b
+20.56%
1,359,671,100909,879,6321,600,457,0162,589,154,7513,719,236,1694,680,646,7506,657,676,0628,001,553,6069,607,174,09411,582,226,085
CFO
11.06b
-8.89%
1,741,478,7002,023,902,7073,039,526,4873,300,366,9194,034,585,3764,721,794,9158,870,109,8498,998,649,17512,141,147,87611,062,025,295
Dividend
Sep 09, 20244.06 CNY/sh
Earnings
May 16, 2025

Profile

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. provides medical devices and solutions worldwide. The company offers patient monitoring and life support products, such as patient monitoring systems, electrocardiographs, defibrillators, anesthesia machines, ventilators, infusion pumps, surgical lights, operating tables, medical supply units, endoscopes, and accessories, as well as emergency care, peri-operative care, critical care, and IT solutions. It also provides in-vitro diagnostics products, including hematology and chemistry analyzers and reagents, chemiluminescence immunoassay products, hemoglobin systems, flow cytometry products, and micro plate readers and washers, as well as coagulation, urinalysis, and microbiology solutions; medical imaging systems comprising ultrasound and radiology products; and veterinary products. The company was founded in 1991 and is headquartered in Shenzhen, the People's Republic of China.
URL
https://www.mindray.com/
IPO date
Oct 16, 2018
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑12
Income
Revenues
34,931,901
15.04%
30,365,644
20.17%
Cost of revenue
21,408,791
18,971,403
Unusual Expense (Income)
NOPBT
13,523,110
11,394,241
NOPBT Margin
38.71%
37.52%
Operating Taxes
1,432,517
1,342,834
Tax Rate
10.59%
11.79%
NOPAT
12,090,594
10,051,407
Net income
11,582,226
20.56%
9,607,174
20.07%
Dividends
(10,669,617)
(4,232,875)
Dividend yield
3.03%
1.11%
Proceeds from repurchase of equity
(6,075)
(847,511)
BB yield
0.00%
0.22%
Debt
Debt current
192,877
97,217
Long-term debt
363,527
278,615
Deferred revenue
180,856
92,943
Other long-term liabilities
3,850,328
2,560,933
Net debt
(21,495,043)
(24,597,699)
Cash flow
Cash from operating activities
11,062,025
12,141,148
CAPEX
(2,688,668)
(1,915,528)
Cash from investing activities
(692,932)
(3,219,771)
Cash from financing activities
(10,775,686)
(5,194,278)
FCF
10,018,476
8,893,230
Balance
Cash
18,787,180
23,185,663
Long term investments
3,264,266
1,787,867
Excess cash
20,304,851
23,455,248
Stockholders' equity
26,153,425
24,991,440
Invested Capital
17,371,885
10,860,862
ROIC
85.65%
78.96%
ROCE
35.73%
33.03%
EV
Common stock shares outstanding
1,211,821
1,210,444
Price
291.02
-7.90%
315.97
-17.02%
Market cap
352,664,285
-7.79%
382,464,036
-17.32%
EV
331,429,892
358,248,230
EBITDA
14,562,283
12,279,297
EV/EBITDA
22.76
29.17
Interest
85,899
10,687
Interest/NOPBT
0.64%
0.09%